Liver function tests in hepatitis C virus infected kidney transplant recipients
Manfro, R.C.; Karohl, C.; Goncalves, L.F.; Senger, M.B.; Thomé, F.S.; Prompt, C.A.
Transplantation Proceedings 27(2): 1821-1822
1995
ISSN/ISBN: 0041-1345 PMID: 7725519 Document Number: 446781
Document emailed within 1 workday
Related Documents
Stahel, E.; Tanner, M.; Gyr, N.; Weiss, N.; Hess, C.; Betschart, B. 1984: Seroepidemiology of hepatitis B virus in rural Tanzania: relation of hepatitis B markers and liver function tests in patients with clinical liver disease and in healthy controls East African Medical Journal 61(11): 806-811Stark, K.; Meyer, C.G.; Tacke, M.; Schwarz, A.; Braun, C.; Huzly, D.; Engel, A.M.; May, J.; Bienzle, U. 1997: Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors Transplantation 64(4): 608-612
Yagisawa, T. 1988: Clinical and pathological studies of cyclosporin-treated kidney transplant recipients. First report: Study of recipients with long-term graft function Nihon Jinzo Gakkai Shi 30(7): 865-873
Trull, A.; Hue, K.; Tan, K.; Gore, S.; Whitewood, S.; Smyth, R.; Scott, J.; Price, C.; Wallwork, J. 1990: Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients Clinical Chemistry 36(8 Part 1): 1474-1478
Read, A.E.; Donegan, E.; Lake, J.; Ferrell, L.; Galbraith, C.; Kuramoto, I.K.; Zeldis, J.B.; Ascher, N.L.; Roberts, J.; Wright, T.L. 1991: Hepatitis C in liver transplant recipients Transplantation Proceedings 23(1 Part 2): 1504-1505
Ianhez, L.E.; Chocair, P.R.; Fonseca, J.A.; Arap, S.; Sabbaga, E. 1989: Follow-up of 105 kidney transplant recipients with more than ten years of function Transplantation Proceedings 21(1 Pt 2): 2190-2191
Markin, R.S.; Langnas, A.N.; Donovan, J.P.; Zetterman, R.K.; Stratta, R.J. 1991: Opportunistic viral hepatitis in liver transplant recipients Transplantation Proceedings 23(1 Part 2): 1520-1521
Schvoerer, E.; Kabissa, I.; Cotto, E.; Jouvencel, A-Christine.; Balabaud, C.; De Ledinghen, V.; Couzigou, P.; Quinton, Aé.; Schvoerer, C.; Lafon, M-Edith.; Fleury, Hé.; Bernard, P-Henri. 2002: Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients Gastroenterologie Clinique et Biologique 26(1): 62-66
Lauzurica, R.; Frías, C.; Bayés, B.; Ausina, V.; Romero, R. 2005: Variability in Epstein-Barr virus serological markers in adult kidney transplant recipients Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 25(2): 185-190
Gohar, S.A.; Khalil, R.Y.; Elaish, N.M.; Khedr, E.M.; Ahmed, M.S. 1995: Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients Journal of the Egyptian Public Health Association 70(5-6): 465-484
Szpotanska-Sikorska, M.; Pietrzak, B.; Wielgos, M. 2014: Contraceptive awareness and birth control selection in female kidney and liver transplant recipients Contraception 90(4): 435-439
Rostaing, L.; Izopet, J.; Baron, E.; Duffaut, M.; Puel, J.; Durand, D. 1995: Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects Transplantation Proceedings 27(1): 948-950
Ternesten-Bratel, A.; Kjellström, C.; Wennberg, A.-M.; Ricksten, A. 2003: Cutaneous squamoproliferative lesions in kidney transplant recipients: an investigation of specific Epstein-Barr virus expression Acta Dermato-Venereologica 83(1): 14-17
Górriz, J.L.; Pallardó, L.M.; Sarrión, A.; Sánchez, J.; Rochera, A. 1995: Hepatitis C virus infection in renal transplant recipients: prognostic significance of chronic transaminase elevation Transplantation Proceedings 27(4): 2250-2251
Singh, N.; Gayowski, T.; Wagener, M.M.; Marino, I.R. 1999: Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C Transplantation 67(1): 69-72
Bouzas, L.; Carlos, J. Tutor 2011: Determination of Blood Everolimus Concentrations in Kidney and Liver Transplant Recipients Using the Sirolimus Antibody Conjugated Magnetic Immunoassay (ACMIA) Clinical Laboratory 57(5-6): 403-406
Marcen, R.; Pascual, J.; Orofino, L.; Fernandez Muñoz, R.; Teruel, J.L.; Celma, M.L.; Liaño, F.; Ortuño, J. 1992: Hepatitis C virus infection in kidney transplant patients Transplantation Proceedings 24(1): 87-88
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Tredger, J.M.; Steward, C.M.; Williams, R. 1988: Blood cyclosporine concentrations in liver transplant recipients: assay method and influence of changed hepatic and renal function Transplantation Proceedings 20(3 Suppl 3: 391-393
Kogan, D.L.; Burroughs, M.; Emre, S.; Fishbein, T.; Moscona, A.; Ramson, C.; Shneider, B.L. 1999: Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients Transplantation 67(7): 1068-1070